(TBPH) Theravance Biopharma complete technical analysis [charts+indicators] | Buy/Sell Theravance Biopharma | (TBPH) share price targets
Complete technical analysis of Theravance Biopharma (TBPH) by charts plus indicators, forecast predictions and share price targets for Theravance Biopharma (TBPH)
Theravance Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-01 View latest technical analysis
10 day averaged volume of Theravance Biopharma is 231220
Date | Daily Closing Price | Open | High | Low | Volume |
01 Tue Oct 2024 | 8.21 | 8.06 | 8.28 | 8.04 | 0.977 times |
30 Mon Sep 2024 | 8.06 | 8.07 | 8.15 | 8.02 | 1.039 times |
27 Fri Sep 2024 | 8.10 | 8.12 | 8.15 | 8.05 | 0.705 times |
26 Thu Sep 2024 | 8.06 | 7.96 | 8.12 | 7.93 | 0.666 times |
25 Wed Sep 2024 | 7.96 | 8.05 | 8.05 | 7.90 | 0.777 times |
24 Tue Sep 2024 | 8.02 | 7.97 | 8.11 | 7.88 | 1.033 times |
23 Mon Sep 2024 | 7.94 | 8.07 | 8.08 | 7.93 | 0.955 times |
20 Fri Sep 2024 | 8.01 | 8.20 | 8.23 | 7.99 | 2.806 times |
19 Thu Sep 2024 | 8.21 | 8.38 | 8.38 | 8.21 | 0.532 times |
18 Wed Sep 2024 | 8.27 | 8.29 | 8.42 | 8.21 | 0.746 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 8.2, but if it comes below 8.2, then a intra day sell could be more profitable.
If you take a sell trade below 8.2, then use 8.2 as stoploss and 8.1 as target. However if you take a buy trade in stock , then use 8.2 as stoploss and 8.3 as target.
Share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Target | 7.44 |
Downside Target | 7.88 |
Upside Target | 8.24 |
Upside Target | 8.28 |
Upside Target | 8.42 |
Upside Target | 9.01 |
Upside Target | 10.22 |
Upside Target | 10.42 |
Intraday share price targets for Theravance Biopharma (TBPH)
Target Type | Value |
Downside Intraday Target | 8.06 |
Downside Intraday Target | 7.91 |
Upside Intraday Target | 8.32 |
Upside Intraday Target | 8.43 |
Downside Intraday Target | 8.17 |
Weekly technical analysis of Theravance Biopharma (TBPH)
Date | Weekly Closing Price | Open | High | Low | Volume |
01 Tue Oct 2024 | 8.21 | 8.07 | 8.28 | 8.02 | 0.488 times |
27 Fri Sep 2024 | 8.10 | 8.07 | 8.15 | 7.88 | 0.758 times |
20 Fri Sep 2024 | 8.01 | 8.19 | 8.42 | 7.99 | 1.216 times |
13 Fri Sep 2024 | 8.14 | 8.03 | 8.20 | 7.90 | 1.284 times |
06 Fri Sep 2024 | 8.01 | 8.18 | 8.24 | 7.94 | 3.405 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Theravance Biopharma (TBPH)
Date | Monthly Closing Price | Open | High | Low | Volume |
01 Tue Oct 2024 | 8.21 | 8.06 | 8.28 | 8.04 | 0.053 times |
30 Mon Sep 2024 | 8.06 | 8.18 | 8.42 | 7.88 | 0.378 times |
30 Fri Aug 2024 | 8.25 | 10.16 | 10.22 | 7.44 | 1.459 times |
31 Wed Jul 2024 | 10.11 | 8.46 | 10.42 | 8.19 | 1.048 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Theravance Biopharma (TBPH)
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Theravance Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.06 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Theravance Biopharma ( (TBPH) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Theravance Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Theravance Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Theravance Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Theravance Biopharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Theravance Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.06 and Theravance Biopharma (TBPH) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Theravance Biopharma (TBPH) stock. Volume based technical analysis of Theravance Biopharma (TBPH) stock is negative.
Theravance Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.